close

Clinical Trials

1 207 208 209 210
Number of results: 4199

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-02-02 AS1413 (amonafide) high-grade brain tumors 3 Antisoma (UK) Cancer Oncology
2011-02-01 Imvamune®

smallpox in individuals suffering from atopic dermatitis

2 Bavarian Nordic (Denmark) Infectious diseases
2011-01-31 Tarceva® (erlotinib) advanced, metastatic pancreatic cancer in patients refractory to 1st line gemcitabine treatment 3 Roche (Switzerland) Cancer Oncology
2011-01-28 Almorexant

primary insomnia

3 Actelion (Switzerland)GSK (UK) CNS diseases - Neurological diseases
2011-01-28 masitinib secondary acute myeloid leukaemia 3 AB Science (France) Cancer Oncology
2011-01-27 BSI-201 (iniparib) metastatic triple-negative breast cancer 3 Sanofi-Aventis (France) CancerOncology
2011-01-27 Cytotect® (anti-cytomegalovirus hyperimmunoglobulin) cytomegalovirus infection 3 Biotest (Germany) Infectious diseases
2011-01-27 AM-101 inner ear tinnitus 1-2 Auris Medical (Switzerland) Otorhinolaryngology
2011-01-24 SBG

wound healing

preclinical Biotec Pharmacon (Norway)
2011-01-24 GSK’436 advanced or metastatic melanoma with a BRAF V600 mutation 3 GSK (UK) Cancer Oncology
2011-01-24 GSK’212 advanced/metastatic melanoma focuses on patients with BRAF V600 mutation who have had no more than one prior regimen of chemotherapy and no prior BRAF inhibitor treatment 3 GSK (UK) Cancer Oncology
2011-01-20 Erbitux (cetuximab)

KRAS wild-type metastatic colorectal cancer (mCRC)

2 Merck Serono, a Merck KGaA company (Germany) Cancer - Oncology
2011-01-20 zicronapine (Lu 31-130)

schizophrenia

3 Lundbeck (Denmark) Mental diseases - CNS diseases
2011-01-19 RG7204 The product is being co-developed under a 2006 license and collaboration agreement between Roche and Plexxikon. BRAF V600 mutation-positive metastatic melanoma. 3 Roche (Switzerland) CancerOncology
2011-01-19 zanamivir influenza 3 GSK (UK) Infectious diseases
2011-01-18 VEGF Trap-Eye (aflibercept ophthalmic solution)

choroidal neovascularisation (CNV) of the retina as a result of pathologic myopia

3 Bayer HealthCare (Germany) Regeneron Pharmaceuticals (USA) Ophtalmology
2011-01-17 talactoferrin severe sepsis 2 Agennix (Germany) Infectious diseases
2011-01-12 MEDI-565 (MT111) advanced gastrointestinal cancer 1 Medimmune (USA) Micromet (USA-Germany) Cancer - Oncology
2011-01-12 Vyvanse® (lisdexamfetamine dimesylate)

Excessive Daytime Sleepiness

Shire (UK-USA) CNS diseases
2011-01-11 biosimilar rituximab rheumatoid arthritis 2 Sandoz (Switzerland) Autoimmune diseases – Inflammatory diseases - Rheumatic diseases